Lilly’s Covid-19 antibody helps patients rid their systems of virus sooner
Lilly, which is developing the drug with the biotechnology firm Abcellera, tested three doses of its antibody against placebo
Lilly, which is developing the drug with the biotechnology firm Abcellera, tested three doses of its antibody against placebo
Scientists at Scripps Research have developed atomic-level structural models of enzymes linked to autoimmune and inflammatory conditions, such as lupus and Alzheimer’s disease. When nucleic…
The John C. Martin Memorial Lectureship at Scripps Research was conceived as an annual event where colleagues, friends and family could gather to honor John…
LA JOLLA, CA — Inspired by what human liver enzymes can do, Scripps Research chemists have developed a new set of copper-catalyzed organic synthesis reactions…
April 2024 | 37 min 34 sec Donna Blackmond never thought her career would lead to solving how life first formed on the prebiotic Earth.…
Science and biotech thought leaders gathered in March for the first event in the Biotech CEO Salon series, featuring an engaging discussion about Scripps Research…
April 2024 | 37 min 34 sec Donna Blackmond never thought her career would lead to solving how life first formed on the prebiotic Earth.…
Michael Bollong, PhD, associate professor of chemistry and the Early Career Endowed Roon Chair for Cardiovascular Research at Scripps Research, has received the David W.…
US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news…
Blocking long phosphate molecules could eventually help treat chronic infections in which slow-growing bacteria evade typical antibiotics. LA JOLLA, CA — Most disease-causing bacteria are…
Conference and exhibition covering antibodies, immunotherapy, and clinical trials. 350+ speakers, 60+ exhibitors